Relmada Therapeutics Company Insiders

Relmada Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (1.0241) % which means that it has lost $1.0241 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.9679) %, meaning that it created substantial loss on money invested by shareholders. Relmada Therapeutics' management efficiency ratios could be used to measure how well Relmada Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of February 13, 2026, Return On Tangible Assets is expected to decline to -2.11. The current year's Return On Capital Employed is expected to grow to -2.02. At present, Relmada Therapeutics' Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 68.2 M, whereas Non Currrent Assets Other are forecasted to decline to about 18.8 K. The current year's Common Stock Shares Outstanding is expected to grow to about 36.4 M, whereas Net Loss is forecasted to decline to (148.4 M). Relmada Therapeutics owns a total of 73.33 Million outstanding shares. Relmada Therapeutics holds 10.75 pct. of its outstanding shares held by insiders and 18.88 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Relmada Therapeutics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Relmada Therapeutics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Relmada Therapeutics Workforce Comparison

Relmada Therapeutics Insider Trading History

Relmada Therapeutics Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Relmada Therapeutics often depends on how effective the management is. Relmada Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Relmada management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Relmada management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Relmada Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Relmada Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Relmada Therapeutics' management manipulating its earnings.

When running Relmada Therapeutics' price analysis, check to measure Relmada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relmada Therapeutics is operating at the current time. Most of Relmada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relmada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relmada Therapeutics' price. Additionally, you may evaluate how the addition of Relmada Therapeutics to your portfolios can decrease your overall portfolio volatility.